James Chopas
Comptroller/Controller/Auditor at APELLIS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 29/04/2024
Profile
James G.
Chopas is currently the Chief Accounting Officer, Treasurer & VP at Apellis Pharmaceuticals, Inc. Prior to his current position, he held various roles including Principal at PAREXEL International Corp., Ernst & Young LLP, and PricewaterhouseCoopers LLP.
From 2010 to 2016, he served as the Vice President-Finance at KBI Biopharma, Inc. He also worked as the Chief Financial Officer, Treasurer, CAO & VP at Radius Health, Inc. from 2018 to 2021.
Additionally, he has experience as a Principal at Thermo Fisher Scientific, Inc. and as the Chief Financial Officer at Cenduit LLC.
Mr. Chopas obtained his graduate degree from Bentley University in 2000 and his undergraduate degree from the University of Massachusetts in 1988.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
14/03/2024 | 38,883 ( 0.03% ) | 2 M $ | 29/04/2024 |
James Chopas active positions
Companies | Position | Start |
---|---|---|
APELLIS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 29/08/2021 |
Former positions of James Chopas
Companies | Position | End |
---|---|---|
RADIUS HEALTH, INC. | Director of Finance/CFO | 25/08/2021 |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Director of Finance/CFO | 31/08/2016 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Training of James Chopas
Bentley University | Graduate Degree |
University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
THERMO FISHER SCIENTIFIC | Health Technology |
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 6 |
---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Commercial Services |
Cenduit LLC
Cenduit LLC Packaged SoftwareTechnology Services Cenduit LLC provides clinical supply chain intelligence, operations management and technology services. It offers drug accountability, custom reporting, and eClinical integration services. The company was founded in May 2007 and is headquartered in Durham, NC. | Technology Services |
PAREXEL International Corp.
PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- James Chopas